COURT-RULING ·Filed Mar 30, 2026

ABT

Abbott Laboratories
NEUTRAL
Impact 3/10
Horizondays Processed6mo ago CourtView Ruling on CourtListener
Actionable Insight • Neutral

Monitor for public release or supplemental filings containing the actual court opinions. Given Abbott's $181B market cap, any individual case would need to involve significant damages or an injunction to move the stock. Watch for future disclosures in 8-Ks or 10-Qs.

DirectionNeutral
Confidencelow
Horizondays
Final — all horizons settled through T+60d
ABT ▼ -11.16% at T+60d
NEUTRAL call ✗ call lost -11.16% · α vs SPY -27.18% · entry $101.86 → $90.49
Entry anchored
Mar 27, 07:16 PM ET
via exchange tick
T+1d
+0.74%
call +0.74% · α -2.15%
$102.61
settled 6mo ago
T+5d
-0.07%
call -0.07% · α -4.37%
$101.79
settled 6mo ago
T+20d
-7.88%
call -7.88% · α -20.48%
$93.83
settled 5mo ago
T+60d
-11.16%
call -11.16% · α -27.18%
$90.49
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Analysis based on filing metadata only — document content was unavailable. Two court rulings against Abbott Laboratories (ABT) were filed in the Northern District of Illinois on March 30, 2026, but the actual opinion texts are inaccessible due to PACER login redirection, preventing any substantive analysis.

Court Ruling Details

Court
United States District Court for the Northern District of Illinois
Court Level
District
Case Type
other
Ruling Type
other
Outcome
PARTIAL — mixed ruling, some claims won/lost
Will It Be Appealed?
N/A (final)
Precedent Risk
LOW

Key Facts

  • Two court rulings (1:25-cv-08650 and 1:25-cv-08927) list Abbott Laboratories as defendant.
  • Both cases filed on March 30, 2026, in the U.S. District Court for the Northern District of Illinois.
  • Actual ruling content is unavailable — documents redirect to PACER login page.

Financial Impact

Unknown — no financial details available from rulings

Risk Factors

  • Potential for material liability if rulings involve product liability, antitrust, or securities fraud at scale.
  • Risk of precedent-setting decisions if these are bellwether or class certification cases.

Market Snapshot

Price
$102.56
Volume
100
Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
71% bullish (35 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 2 court opinions from CourtListener.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-3jx13fxi-ABT
COURT-RULING Data (Synthetic)court-9irzosr1-ABT
22 reports for ABT
Performance horizon
80% Hit rate 4 of 5 directional calls best @ T+20▲ +17.16%Jul 1, 2026
Filters
Rows
Reports for ABT — sortable, filterable
TypeNow
Oct 2, 2026
today
ANALYST-UPGRADE
BULLISH ★ 4/10
$98.00 awaiting T+5awaiting T+5—$96.30 (−1.73%)
Sep 14, 2026
18d ago
Court Ruling
NEUTRAL ★ 1/10
$103.09 $102.98▼ −0.11%▼ −1.77%$96.30 (−6.59%)
Aug 11, 2026
7w ago
Court Ruling
NEUTRAL ★ 2/10
$109.72 $112.68▲ +2.70%▲ +3.10%$96.30 (−12.23%)
Aug 11, 2026
7w ago
Court Ruling
NEUTRAL ★ 1/10
$109.72 $112.68▲ +2.70%▲ +3.10%$96.30 (−12.23%)
Jul 31, 2026
9w ago
Institutional Cluster
MIXED ★ 4/10
$105.70 $107.81▲ +2.00%▼ −1.51%$96.30 (−8.89%)
Jul 31, 2026
9w ago
Court Ruling
NEUTRAL ★ 2/10
$105.70 $107.81▲ +2.00%▼ −1.51%$96.30 (−8.89%)
Jul 24, 2026
10w ago
Court Ruling
BULLISH ★ 5/10
$103.06 $105.61▲ +2.47%▲ +2.10%$96.30 (−6.56%)
Jul 16, 2026
11w ago
8-K
BULLISH ★ 6/10
$98.83 $100.75▲ +1.94%▲ +3.61%$96.30 (−2.56%)
Jul 14, 2026
11w ago
Court Ruling
NEUTRAL ★ 3/10
$88.96 $101.66▲ +14.28%▲ +15.57%$96.30 (+8.25%)
Jul 7, 2026
12w ago
Court Ruling
NEUTRAL ★ 1/10
$95.84 $88.96▼ −7.18%▼ −7.73%$96.30 (+0.48%)
Showing 10 of 22

US Market Status

Market Open — Closes in 6h 28m

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access